Literature DB >> 27920026

The Transcellular Propagation and Intracellular Trafficking of α-Synuclein.

George K Tofaris1, Michel Goedert2, Maria Grazia Spillantini3.   

Abstract

Parkinson's disease is the second most common neurodegenerative disorder, with only partial symptomatic therapy and no mechanism-based therapies. The accumulation and aggregation of α-synuclein is causatively linked to the sporadic form of the disease, which accounts for 95% of cases. The pathology is a result of a gain of toxic function of misfolded α-synuclein conformers, which can template the aggregation of soluble monomers and lead to cellular dysfunction, at least partly by interfering with membrane fusion events at synaptic terminals. Here, we discuss the transcellular propagation and intracellular trafficking of α-synuclein and posit that endosomal processing could be a point of convergence between these two routes. Understanding these events will clarify the therapeutic potential of enzymes that regulate protein trafficking and degradation in synucleinopathies.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27920026      PMCID: PMC5580513          DOI: 10.1101/cshperspect.a024380

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  118 in total

1.  Evidence for a partially folded intermediate in alpha-synuclein fibril formation.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

Authors:  B I Giasson; I V Murray; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

3.  Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein.

Authors:  J Y Sung; J Kim; S R Paik; J H Park; Y S Ahn; K C Chung
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

4.  PRA isoforms are targeted to distinct membrane compartments.

Authors:  M Abdul-Ghani; P Y Gougeon; D C Prosser; L F Da-Silva; J K Ngsee
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

5.  Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.

Authors:  George K Tofaris; Azam Razzaq; Bernardino Ghetti; Kathryn S Lilley; Maria Grazia Spillantini
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

6.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

7.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

8.  Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.

Authors:  J Li; V N Uversky; A L Fink
Journal:  Biochemistry       Date:  2001-09-25       Impact factor: 3.162

9.  Alpha-Synuclein is degraded by both autophagy and the proteasome.

Authors:  Julie L Webb; Brinda Ravikumar; Jane Atkins; Jeremy N Skepper; David C Rubinsztein
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

10.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

View more
  9 in total

Review 1.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

2.  Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.

Authors:  Hideki Hayakawa; Rie Nakatani; Kensuke Ikenaka; Cesar Aguirre; Chi-Jing Choong; Hiroshi Tsuda; Seiichi Nagano; Masato Koike; Takeshi Ikeuchi; Masato Hasegawa; Stella M Papa; Yoshitaka Nagai; Hideki Mochizuki; Kousuke Baba
Journal:  Mov Disord       Date:  2019-10-23       Impact factor: 10.338

3.  Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.

Authors:  Amanda L Woerman; Sabeen A Kazmi; Smita Patel; Atsushi Aoyagi; Abby Oehler; Kartika Widjaja; Daniel A Mordes; Steven H Olson; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

Review 4.  α-Synuclein: Multiple System Atrophy Prions.

Authors:  Amanda L Woerman; Joel C Watts; Atsushi Aoyagi; Kurt Giles; Lefkos T Middleton; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

5.  The dual role of c-src in cell-to-cell transmission of α-synuclein.

Authors:  Yu Ree Choi; Jae-Bong Kim; Seo-Jun Kang; Hye Rin Noh; Ilo Jou; Eun-Hye Joe; Sang Myun Park
Journal:  EMBO Rep       Date:  2020-05-05       Impact factor: 8.807

Review 6.  Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.

Authors:  Vladimir N Uversky
Journal:  F1000Res       Date:  2017-04-20

7.  Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.

Authors:  Ya-Nan Zhang; Jing-Kai Fan; Li Gu; Hui-Min Yang; Shu-Qin Zhan; Hong Zhang
Journal:  J Neuroinflammation       Date:  2021-01-18       Impact factor: 8.322

Review 8.  Initiation and progression of α-synuclein pathology in Parkinson's disease.

Authors:  George K Tofaris
Journal:  Cell Mol Life Sci       Date:  2022-03-26       Impact factor: 9.207

Review 9.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.